4 Recruiting Hematological Malignancies Phase 1 Clinical Trials
Active phase 1 studies for hematological malignancies enrolling across the USA. Verify eligibility and contact site coordinators.
All Hematological Malignancies studiesPhase 1 Studies for Hematological Malignancies
🔵 Active, Not Recruiting Phase1
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
📍 University of Alabama Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma
📍 City of Hope — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT
📍 Memorial Sloan Kettering Cancer Center (MSKCC) — New York, New York
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
📍 Research Site — New York, New York
View Study & Checklist ➔